Clinical Trials · NCT03421119
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Cinnagen
- Enrollment
- 300
- Start date
- Jun 2019
- Locations
- See registry
- Primary endpoint
- HbA1c